首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
【24h】

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

机译:同种异体造血干细胞移植受者的血流感染:革兰氏阴性棒再次出现,抗生素耐药性增加。

获取原文
获取原文并翻译 | 示例
           

摘要

Blood stream infections (BSI) are a well-known cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) patients. The aim of this study was to analyze etiology and microbial resistance of BSI in patients undergoing allogeneic HSCT in a single center over a 4-year period (2004-2007). There were 168 episodes of BSI in 132 patients (median 10 days after HSCT) and 182 pathogens were isolated. Gram-positive bacteria (GPB) accounted for 57% of 182 isolates. Gram-negative rods (GNR) for 37% and fungi for 6%. All patients received routine fluoroquinolone prophylaxis. There was a significant decrease in GPB/GNR ratio over time, from 2.4 in 2004 to 1 in 2007 (P = .043). Among GPB, staphylococci decreased from 37 of 68 (64%) in 2004-2005 to 8 of 35 (23%) in 2006-2007 (P < .002). The Enterococcus faecalis/E. faecium ratio decreased from 4.5 in 2004 to 0.33 in 2007 (P = .006), whereas the total number of enterococcal strains per year did not change. The incidence of Escherichia coli among GNR increased from 3 of 15 (20%) in 2004 to 13 of 21 (62%) in 2007 (P = .003). Fluoroquinolone-resistance was common, both among GPB and GNR (81% and 74%, respectively). Mortality rate at 7 days after BSI was 11% (19 of 168), reaching 39% for Pseudomonas aeruginosa BSI (7 of 18). BSI remains a frequent and potentially life-threatening complication of allogeneic HSCT, the causative organism influencing 7- and 30-day mortality rate. BSI etiology may change rapidly, requiring implementation of new empirical-therapy schemes.
机译:血流感染(BSI)是造血干细胞移植(HSCT)患者发病和死亡的众所周知原因。这项研究的目的是分析在一个单一中心接受异基因HSCT的患者在4年期间(2004-2007年)的BSI病因和微生物耐药性。 132例患者中有168次BSI发作(HSCT后中位数为10天),分离出182种病原体。革兰氏阳性细菌(GPB)占182株分离株的57%。革兰氏阴性棒(GNR)占37%,真菌占6%。所有患者均接受常规氟喹诺酮类预防。随着时间的推移,GPB / GNR比率显着下降,从2004年的2.4下降到2007年的1(P = .043)。在GPB中,葡萄球菌从2004-2005年的68个中的37个(64%)降至2006-2007年的35个中的8个(23%)(P <.002)。粪肠球菌/ E。粪便比率从2004年的4.5下降到2007年的0.33(P = .006),而每年的肠球菌菌株总数没有变化。 GNR中大肠杆菌的发生率从2004年的15中的3(20%)增加到2007年的21中的13(62%)(P = .003)。在GPB和GNR中,氟喹诺酮耐药性很常见(分别为81%和74%)。 BSI后7天的死亡率为11%(168个中的19个),铜绿假单胞菌BSI达到39%(18个中的7个)。 BSI仍然是同种异体HSCT的常见且可能危及生命的并发症,这是影响7天和30天死亡率的致病菌。 BSI病因可能会迅速改变,需要实施新的经验疗法方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号